According to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19...
Read more
The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase...
Read more
The data is undeniable: COVID-19 instances and hospitalizations are on the rise in the United States, despite patchy documentation. Most...
Read more
Pfizer officials stated on an earnings call that while Paxlovid's first-quarter sales may seem to be low, there will be plenty...
Read more
Austedo, Teva's tardive dyskinesia (TD) therapy, has great prospects. Now the company only needs to worry about one less generic...
Read more
According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of...
Read more
Bristol Myers Squibb has gained approval for one of the year's most anticipated medications, following a brief delay in November....
Read more
Sanofi's Dupixent is still breaking new ground in inflammatory illnesses five years after receiving FDA approval for the first time...
Read more
The pharma version of Fast and Furious has a new superhero. How else to characterise AbbVie's Rinvoq's breakthrough effectiveness? The...
Read more
Catalent, the high-flying CDMO, is buying a cell therapy unit on the East Coast, only days after spending $350 million...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
